MassachusettsWomen Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Women are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Population Estimate Benchmark Distance to Benchmark
Adults who received a blood cholesterol measurement in the last 5 years Female 88.0 82.3 Achieved: 7% better
Women ages 50-74 who received a mammogram in the last 2 years Total 86.0 84.7 Achieved: 2% better
Women ages 21-65 who received a Pap smear in the last 3 years Total 84.1 84.2 0.1%
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over Total 8.0 7.7 3.6%
Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy to the breast within 1 year of diagnosis Total 92.5 96.2 3.8%
Breast cancer deaths per 100,000 female population per year Total 18.5 17.8 4.0%
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over Total 79.5 73.8 7.8%
Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy) Total 87.9 96.4 8.8%
Measures That Are Far From Benchmark
Measure Population Estimate Benchmark Distance to Benchmark
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population Female 429.5 102.9 317.6%
Emergency department visits involving opioid-related diagnoses per 100,000 population Female 363.8 65.2 457.5%
Measures With No Available Benchmark Information
Measure Population Estimate Benchmark Distance to Benchmark
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year Female
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season Female
Adults age 65 and over who received an influenza vaccination in the last flu season Female
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination Female
Adults age 65 and over who ever received pneumococcal vaccination Female
Adolescents females ages 13-15 who received 3 or more doses human papillomavirus vaccine Total
Adolescents females ages 16-17 who received 3 or more doses human papillomavirus vaccine Total